UB Therapeutics
Therapy for the Treatment of Multiple Myeloma
StartupUB Therapeutics is a Nazareth-based startup in the Health Tech & Life Sciences sector, established in 2023. Therapy for the Treatment of Multiple Myeloma. The company has raised a total of $415.42K across 1 funding round, currently at the Pre-Seed stage. UB Therapeutics was founded by Ashraf Brik. Key investors include NGT HealthCare II, Israel Innovation Authority. The company has 1-10 employees. Core technologies: Biologicals, Molecules.
With $415.42K in total funding, UB Therapeutics is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B2C business model. Product stage: R&D.
- StagePre-Seed
- ProductR&D
- ModelB2B2C
- Employees1-10
- HQNazareth
- Last Round$415.42K
- NGT HealthCare II
- Israel Innovation Authority
Ashraf BrikFounder
1 article covered by sources including www.calcalistech.com.
What does UB Therapeutics do?
UB Therapeutics is a biotechnology company developing a novel therapy for the treatment of multiple myeloma. The company’s compound is a cyclic peptide with potential anticancer therapeutic activity. The cyclic peptides block the action of deubiquitinases and the proteasome, induce apoptosis in vitro, and attenuate tumor growth in vivo. These cyclic peptides show in vitro and in vivo activity comparable to a small molecule proteasome inhibitor and similarly induce apoptosis in cancer cells. Whereas the immediate target of small molecules proteasome inhibitors such as bortezomib is the chymotrypsin-like β5 catalytic subunit of the proteasome, the cyclic peptides impair the recognition and subsequent proteasomal degradation of ubiquitinylated proteins.
How much funding has UB Therapeutics raised?
UB Therapeutics has raised $415.42K in total funding across 1 rounds. The company is currently at the Pre-Seed stage. Key investors include NGT HealthCare II, Israel Innovation Authority.
Who founded UB Therapeutics?
UB Therapeutics was founded in 2023 by Ashraf Brik (Founder).
What sector is UB Therapeutics in?
UB Therapeutics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Biotechnology.
Where is UB Therapeutics located?
UB Therapeutics is based in Wadi el-Haj St 13, Nazareth, Israel.